654 related articles for article (PubMed ID: 8322763)
21. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children.
Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C
P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673
[TBL] [Abstract][Full Text] [Related]
22. Pentavalent DTP vaccine: need to be incorporated in the vaccination program of India.
Verma R; Khanna P; Chawla S
Hum Vaccin Immunother; 2013 Jul; 9(7):1497-9. PubMed ID: 23571225
[TBL] [Abstract][Full Text] [Related]
23. Estimating the economic impact of pneumococcal conjugate, Haemophilus influenzae type b and rotavirus vaccines in India: National and state-level analyses.
Constenla D; Liu T
Vaccine; 2019 Dec; 37(52):7547-7559. PubMed ID: 31607600
[TBL] [Abstract][Full Text] [Related]
24. Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran.
Teimouri F; Kebriaeezadeh A; Zahraei SM; Gheiratian M; Nikfar S
Daru; 2017 Jan; 25(1):1. PubMed ID: 28088246
[TBL] [Abstract][Full Text] [Related]
25. Impact of haemophilus influenzae type b conjugate vaccine in South Africa and Argentina.
Martin M; Casellas JM; Madhi SA; Urquhart TJ; Delport SD; Ferrero F; Chamany S; Dayan GH; Rose CE; Levine OS; Klugman KP; Feikin DR
Pediatr Infect Dis J; 2004 Sep; 23(9):842-7. PubMed ID: 15361724
[TBL] [Abstract][Full Text] [Related]
26. Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis.
Zhou F; Bisgard KM; Yusuf HR; Deuson RR; Bath SK; Murphy TV
Pediatrics; 2002 Oct; 110(4):653-61. PubMed ID: 12359777
[TBL] [Abstract][Full Text] [Related]
27. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study.
Adegbola RA; Secka O; Lahai G; Lloyd-Evans N; Njie A; Usen S; Oluwalana C; Obaro S; Weber M; Corrah T; Mulholland K; McAdam K; Greenwood B; Milligan PJ
Lancet; 2005 Jul 9-15; 366(9480):144-50. PubMed ID: 16005337
[TBL] [Abstract][Full Text] [Related]
28. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB).
Bar-On ES; Goldberg E; Fraser A; Vidal L; Hellmann S; Leibovici L
Cochrane Database Syst Rev; 2009 Jul; (3):CD005530. PubMed ID: 19588375
[TBL] [Abstract][Full Text] [Related]
29. Global reduction of Hib disease: what are the next steps? Proceedings of the meeting Scottsdale, Arizona, September 22-25, 2002.
Watt JP; Levine OS; Santosham M
J Pediatr; 2003 Dec; 143(6 Suppl):S163-87. PubMed ID: 14657805
[TBL] [Abstract][Full Text] [Related]
30. [Effect of conjugated PRP vaccines on the incidence of invasive diseases caused by Haemophilus influenzae Type B in childhood].
Desgrandchamps D; Schmid R; Zimmermann HP; Imahorn P; Kabus K; Schubiger G
Schweiz Med Wochenschr; 1994 Apr; 124(14):575-82. PubMed ID: 8184297
[TBL] [Abstract][Full Text] [Related]
31. Economic evaluation of delivering Haemophilus influenzae type b vaccine in routine immunization services in Kenya.
Akumu AO; English M; Scott JA; Griffiths UK
Bull World Health Organ; 2007 Jul; 85(7):511-8. PubMed ID: 17768499
[TBL] [Abstract][Full Text] [Related]
32. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era.
Adams WG; Deaver KA; Cochi SL; Plikaytis BD; Zell ER; Broome CV; Wenger JD
JAMA; 1993 Jan; 269(2):221-6. PubMed ID: 8417239
[TBL] [Abstract][Full Text] [Related]
33. Impact of immunization on Haemophilus influenzae type b disease.
Madore DV
Infect Agents Dis; 1996 Jan; 5(1):8-20. PubMed ID: 8789595
[TBL] [Abstract][Full Text] [Related]
34. Conjugate vaccines for preventing Haemophilus influenzae type b infections.
Swingler G; Fransman D; Hussey G
Cochrane Database Syst Rev; 2003; (4):CD001729. PubMed ID: 14583937
[TBL] [Abstract][Full Text] [Related]
35. Incidence of Haemophilus influenzae type b and other invasive diseases in South Korean children.
Kim JS; Jang YT; Kim JD; Park TH; Park JM; Kilgore PE; Kennedy WA; Park E; Nyambat B; Kim DR; Hwang PH; Kim SJ; Eun SH; Lee HS; Cho JH; Kim YS; Chang SJ; Huang HF; Clemens JD; Ward JI
Vaccine; 2004 Sep; 22(29-30):3952-62. PubMed ID: 15364444
[TBL] [Abstract][Full Text] [Related]
36. Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates.
Watt JP; Wolfson LJ; O'Brien KL; Henkle E; Deloria-Knoll M; McCall N; Lee E; Levine OS; Hajjeh R; Mulholland K; Cherian T;
Lancet; 2009 Sep; 374(9693):903-11. PubMed ID: 19748399
[TBL] [Abstract][Full Text] [Related]
37. Rapid disappearance of Haemophilus influenzae type b meningitis after routine childhood immunisation with conjugate vaccines.
Peltola H; Kilpi T; Anttila M
Lancet; 1992 Sep; 340(8819):592-4. PubMed ID: 1355165
[TBL] [Abstract][Full Text] [Related]
38. A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan.
Suga S; Ishiwada N; Sasaki Y; Akeda H; Nishi J; Okada K; Fujieda M; Oda M; Asada K; Nakano T; Saitoh A; Hosoya M; Togashi T; Matsuoka M; Kimura K; Shibayama K
Vaccine; 2018 Sep; 36(38):5678-5684. PubMed ID: 30122645
[TBL] [Abstract][Full Text] [Related]
39. Economic aspects of a general vaccination against invasive disease caused by Haemophilus influenzae type b (Hib) via the experience of the Children's Hospital La Fe, Valencia, Spain.
Asensi F; Otero MC; Pérez-Tamarit D; Miranda J; Picó L; Nieto A
Vaccine; 1995 Nov; 13(16):1563-6. PubMed ID: 8578843
[TBL] [Abstract][Full Text] [Related]
40. TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination.
Clark A; Jauregui B; Griffiths U; Janusz CB; Bolaños-Sierra B; Hajjeh R; Andrus JK; Sanderson C
Vaccine; 2013 Jul; 31 Suppl 3():C19-29. PubMed ID: 23777686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
